Knowledge, Perceptions and Acceptability of HPV Vaccination among Medical Students in Chongqing, China |
Fu, Chun-Jing
(Department of Health Statistics and Information Management, School of Public Health and Management, Chongqing Medical University)
Pan, Xiong-Fei (Department of Epidemiology, West China School of Public Health, Sichuan University) Zhao, Zhi-Mei (Department of Epidemiology, West China School of Public Health, Sichuan University) Saheb-Kashaf, Michael (Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine) Chen, Feng (Department of Preventive Healthcare and Hospital Infection Control, People's Hospital of Deyang) Wen, Ying (Department of Epidemiology, West China School of Public Health, Sichuan University) Yang, Chun-Xia (Department of Epidemiology, West China School of Public Health, Sichuan University) Zhong, Xiao-Ni (Department of Health Statistics and Information Management, School of Public Health and Management, Chongqing Medical University) |
1 | Kahn JA, Rosenthal SL, Hamann T, Bernstein DI (2003). Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS, 14, 300-6. DOI ScienceOn |
2 | Kwan TT, Chan KK, Yip AM, et al (2009). Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications. BJOG, 116, 501-10. DOI ScienceOn |
3 | Kwan TT, Chan KK, Yip AM, et al (2008). Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitativequantitative study. Sex Transm Infect, 84, 227-32. DOI ScienceOn |
4 | Lee PW, Kwan TT, Tam KF, et al (2007). Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong. Prev Med, 45, 130-4. DOI ScienceOn |
5 | Li J, Li LK, Ma JF, et al (2009). Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine, 27, 1210-5. DOI ScienceOn |
6 | Makwe CC, Anorlu RI, Odeyemi KA (2012). Human papillomavirus (HPV) infection and vaccines: Knowledge, attitude and perception among female students at the University of Lagos, Lagos, Nigeria. J Epidemiol Glob Health, 2, 199-206. DOI |
7 | Markowitz LE, Dunne EF, Saraiya M, et al (2007). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 56, 1-24. |
8 | Medeiros R, Ramada D (2010). Knowledge differences between male and female university students about human papillomavirus (HPV) and cervical cancer: Implications for health strategies and vaccination. Vaccine, 29, 153-60. DOI ScienceOn |
9 | Mehta S, Rajaram S, Goel G, Goel N (2013). Awareness about human papilloma virus and its vaccine among medical students. Indian J Community Med, 38, 92-4. DOI |
10 | Ministry of Health in New Zealand (2008). Information on HPV Immunisation Programme-the facts. Available at: http://www.moh.govt.nz/moh.nsf/indexmh/hpv-immunisationprogrammefacts-4aug08; [accessed August 2008]. |
11 | Munoz N, Bosch FX, De Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27. DOI ScienceOn |
12 | Pandey D, Vanya V, Bhagat S, et al (2012). Awareness and attitude towards human papillomavirus (HPV) vaccine among medical students in a premier medical school in India. PLoS One, 7, 40619. DOI |
13 | Rashwan HH, Saat NZNM, Manan DNA (2012). Knowledge, attitude and practice of Malaysian medical and pharmacy students towards human papillomavirus vaccination. Asian Pac J Cancer Prev, 13, 2279-83. 과학기술학회마을 DOI ScienceOn |
14 | Schiller JT, Castellsague X, Garland SM (2012). A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine, 30, 123-38. DOI |
15 | Serrano B, Alemany L, Tous S, et al (2012). Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agent Cancer, 7, 38. DOI ScienceOn |
16 | The Star Online (2009). Cervical cancer vaccination: up to parent. Available at: http://thestar.com.my/news/story.asp?file=/2009/10/8/nation/20091008103513&sec=nation [8 October 2009]. |
17 | Who (2009). Weekly Epidemiological Record 2009:117-32. |
18 | Villa LL, Costa RL, Petta CA, et al (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol, 6, 271-8. DOI ScienceOn |
19 | Weaver BA (2006). Epidemiology and natural history of genital human papillomavirus infection. J Am Osteopath Assoc, 106, 2-8. |
20 | Wei MX, Li SW, Huang B, et al (2009). Production of human papillomavirus type 16 virus-like particles and its immunogenicity. Bing Du Xue Bao, 25, 245-50 (in Chinese). |
21 | Who, Iarc. (2012). Globocan 2012:Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Available at:http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. |
22 | Wong LP, Sam IC (2010). Ethnically diverse female university students' knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer. Eur J Obstet Gynecol Reprod Biol, 148, 90-5. DOI ScienceOn |
23 | Woodhall SC, Lehtinen M, Verho T, et al (2007). Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland. J Adolesc Health, 40, 466-9. DOI ScienceOn |
24 | Zhang SK, Pan XF, Wang SM, et al (2013). Perceptions and acceptability of HPV vaccination among parents of young adolescents: a multicenter national survey in China. Vaccine, 31, 3244-9. DOI ScienceOn |
25 | Zhang YZ, Ma JF, Zhao FH, et al (2010). Three-year follow-up results of visual inspection with acetic acid/Lugol's iodine (VIA/VILI) used as an alternative screening method for cervical cancer in rural areas. Chin J Cancer, 29, 4-8 (in Chinese). DOI |
26 | Boehner CW, Howe SR, Bernstein DI, Rosenthal SL (2003). Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis, 30, 774-8. DOI |
27 | Zhao F-H, Tiggelaar SM, Hu S-Y, et al (2012). A multicenter survey of HPV knowledge and attitudes toward HPVvaccination among women, government officials, and medical personnel in China. Asian Pac J Cancer Prev, 13, 2369-78. DOI ScienceOn |
28 | Zhao FH, Tiggelaar SM, Hu SY, et al (2012). A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in China. Cancer Epidemiol, 36, 384-90. DOI |
29 | Bendik MK, Mayo RM, Parker VG (2011). Knowledge, perceptions, and motivations related to HPV vaccination among college women. J Cancer Educ, 26, 459-64. DOI ScienceOn |
30 | Blumenthal J, Frey MK, Worley MJ, Jr., et al (2012). Adolescent Understanding and Acceptance of the HPV Vaccination in an Underserved Population in New York City. J Oncol, 2012, 904034. |
31 | Bourke L (2012). Acceptance and associated factors of HPV vaccination among young male Malaysians. J Commun Med Health Educ, 01. |
32 | Brown DR, Shew ML, Qadadri B, et al (2005). A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis, 191, 182-92. DOI ScienceOn |
33 | Centers for Disease Control and Prevention (2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep, 59, 626-9. |
34 | Gerend MA, Lee SC, Shepherd JE (2007). Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis, 34, 468-71. |
35 | Chan SS, Cheung TH, Lo WK, Chung TK (2007). Women's attitudes on human papillomavirus vaccination to their daughters. J Adolesc Health, 41, 204-7. DOI ScienceOn |
36 | Davis K, Dickman ED, Ferris D, Dias JK (2004). Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis, 8, 188-94. DOI |
37 | Durusoy R, Yamazhan M, Tasbakan MI, et al (2010). HPV vaccine awareness and willingness of first-year students entering university in Western Turkey. Asian Pac J Cancer Prev, 11, 1695-701. |
38 | Glynn JR, Kayuni N, Floyd S, et al (2010). Age at menarche, schooling, and sexual debut in northern Malawi. PLoS One, 5, 15334. DOI |
39 | Gottvall M, Larsson M, Hoglund AT, Tyden T (2009). High HPV vaccine acceptance despite low awareness among Swedish upper secondary school students. Eur J Contracept Reprod Health Care, 14, 399-405. DOI ScienceOn |
40 | Iliyasu Z, Abubakar IS, Aliyu MH, Galadanci HS (2010). Cervical cancer risk perception and predictors of human papilloma virus vaccine acceptance among female university students in northern Nigeria. J Obstet Gynaecol, 30, 857-62. DOI ScienceOn |
41 | Jones M, Cook R (2008). Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health, 57, 23-32. DOI |
42 | Juntasopeepun P, Suwan N, Phianmongkhol Y, Srisomboon J (2012). Factors influencing acceptance of human papillomavirus vaccine among young female college students in Thailand. Int J Gynaecol Obstet, 118, 247-50. DOI |
43 | Lenselink CH, Gerrits MM, Melchers WJ, et al (2008). Parental acceptance of human papillomavirus vaccines. Eur J Obstet Gynecol Reprod Biol, 137, 103-7. DOI ScienceOn |
44 | Peckham M, Pinedo B, Veronesi U (1995). Oxford textbook of oncology.Sections 8-20 volume 2. Oxford: oxford university press, 1995. |
45 | Australian Government Department of Health and Ageing (2006). Announcement for the human papillomavirus (HPV) vaccination program. . Available at:http://www.health.gov.au/internet/immunise/publishing.nsf/Content/hpv-vac-prog; [accessed August, 2006]. |
![]() |